Literature DB >> 29945687

Prevalence of human papillomavirus types in North and Central regions of Mexico.

C M Luna-Aguirre1, L M Reyes-Cortés1, A A Torres-Grimaldo1, S F Karr-de-León1, R M Cerda-Flores2, B Melo-Nava3, V E Aizpuru-Akel3, H A Barrera-Saldaña1.   

Abstract

Human papillomavirus (HPV) is a DNA virus linked to mucosal and cutaneous carcinogenesis. More than 200 different HPV types exist. We carried out a transversal study to investigate the prevalence of HPV types in two regions of Mexico. A total of 724 genital and non-genital samples from women (F) and men (M) were studied; 241 (33%) from North-Eastern (NE) and 483 (66%) from South-Central (SC) Mexico. The overall prevalence was 87%. In genital lesions from females, the NE group showed a prevalence of HPV types 16 (37%), 6 (13%), 59 (6%), 11, 18 and 66 (5.4% each); and the SC group showed types 6 (17%), 16 (15%), 11 (14.5%), 18 (12%) and 53 (6%). In the genital lesions from males, NE group showed types 16 (38%), 6 (21%), 11 (13%) and 59 plus 31 (7.5%) and the SC group showed types 6 (25%), 11 (22%), 18 (17%) and 16 (11.5%). When the two regions were compared, a higher prevalence of low-risk HPV 6 and 11 was found in the SC region and of high-risk HPV 59, 31 and 66 (the latter can also be present in benign lesions) in the NE region. Our findings complement efforts to understand HPV demographics as a prerequisite to guide and assess the impact of preventive interventions.

Entities:  

Keywords:  Cervical cancer; HVP types; Mexico regions; genotyping

Mesh:

Year:  2018        PMID: 29945687      PMCID: PMC9507946          DOI: 10.1017/S0950268818001747

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  19 in total

1.  Human papillomaviruses.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  2007

2.  Prevalence and 3-year persistence of human papillomavirus serotypes in asymptomatic patients in Northern Mexico.

Authors:  Oscar R Fajardo-Ramírez; María C Barboza-Cerda; Rocío Ortiz-López; Augusto Rojas-Martínez; María L Garza-Rodríguez; Abel Sepúlveda-Flores; Juan F González-Guerrero; Sofía Bernal-Silva; Ricardo M Cerda-Flores; Itzel E Calleja-Macías; Socorro Rodríguez-Flores; Esthela Sandoval-Guzmán; Teresa Plascencia-Solis; Patricia Pérez-Reyes; Jesús Z Villarreal; Hugo A Barrera-Saldaña
Journal:  Int J Gynaecol Obstet       Date:  2016-11-03       Impact factor: 3.561

3.  Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk.

Authors:  M Ortiz; M Torres; L Muñoz; E Fernández-García; J Canals; A I Cabornero; E Aguilar; J Ballesteros; J Del Amo; A García-Sáiz
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology.

Authors:  Asunción Orozco-Colín; Adela Carrillo-García; Alfonso Méndez-Tenorio; Sergio Ponce-de-León; Alejandro Mohar; Rogelio Maldonado-Rodríguez; Rocío Guerra-Arias; Octavio Flores-Gil; Rita Sotelo-Regil; Marcela Lizano
Journal:  Int J Infect Dis       Date:  2010-10-16       Impact factor: 3.623

5.  Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.

Authors:  A R Giuliano; M Papenfuss; M Abrahamsen; C Denman; J G de Zapien; J L Henze; L Ortega; E M Brown de Galaz; J Stephan; J Feng; S Baldwin; F Garcia; K Hatch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-11       Impact factor: 4.254

6.  The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States.

Authors:  Anna R Giuliano; Eduardo Lazcano-Ponce; Luisa L Villa; Roberto Flores; Jorge Salmeron; Ji-Hyun Lee; Mary R Papenfuss; Martha Abrahamsen; Emily Jolles; Carrie M Nielson; Maria Luisa Baggio; Roberto Silva; Manuel Quiterio
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

Review 7.  Classification of papillomaviruses.

Authors:  Ethel-Michele de Villiers; Claude Fauquet; Thomas R Broker; Hans-Ulrich Bernard; Harald zur Hausen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

8.  Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.

Authors:  Suzanne M Garland; Marc Steben; Heather L Sings; Margaret James; Shuang Lu; Radha Railkar; Eliav Barr; Richard M Haupt; Elmar A Joura
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

9.  Prevalence of human papillomavirus in women from Mexico City.

Authors:  María Guadalupe López Rivera; Maria Olivia Medel Flores; José D'Artagnan Villalba Magdaleno; Virginia Sánchez Monroy
Journal:  Infect Dis Obstet Gynecol       Date:  2012-07-02

10.  Low frequency of human papillomavirus infection in conjunctival squamous cell carcinoma of Mexican patients.

Authors:  Raúl Peralta; Alejandra Valdivia; Perla Estañol; Vanessa Villegas; Carolina Pimienta; Eugenio Treviño; Daniel Marrero; Monica Mendoza; Florinda Jimenez; Leonardo Villalvazo; Miriam Tejeda; Mauricio Salcedo
Journal:  Infect Agent Cancer       Date:  2011-11-18       Impact factor: 2.965

View more
  1 in total

1.  Prevalence and Distribution of Human Papillomavirus Genotypes (1997-2019) and Their Association With Cervical Cancer and Precursor Lesions in Women From Southern Mexico.

Authors:  Luz Del Carmen Alarcón-Romero; Jorge Organista-Nava; Yazmín Gómez-Gómez; Julio Ortiz-Ortiz; Daniel Hernández-Sotelo; Oscar Del Moral-Hernández; Miguel Angel Mendoza-Catalán; Ramón Antaño-Arias; Marco Antonio Leyva-Vázquez; Natividad Sales-Linares; Verónica Antonio-Véjar; Berenice Illades-Aguiar
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.